Long-term safety, and efficacy of subcutaneous Efgartigimod PH20 in patients with generalized myasthenia gravis: interim results of ADAPT-SC

被引：2

作者：

Musick, K. ^{[1
]}

Howard, J. ^{[2
]}

Li, G. ^{[3
]}

Vu, T. ^{[4
]}

Korobko, D. ^{[5
]}

Smilowski, M. ^{[6
]}

Liu, L. ^{[1
]}

Steeland, S. ^{[1
]}

Noukens, J. ^{[7
]}

Van Hoorick, B. ^{[1
]}

Podhorna, J. ^{[1
]}

Li, Y. ^{[8
]}

Utsugisawa, K. ^{[9
]}

Sacca, F. ^{[10
]}

Wiendl, H. ^{[11
]}

De Bleecker, J. ^{[12
]}

Mantegazza, R. ^{[13
]}

机构：

[1] Argenx, Ghent, Belgium

[2] Univ N Carolina, Dept Neurol, Chapel Hill, NC USA

[3] Medsol Clin Res Ctr Inc, Port Charlotte, FL USA

[4] Univ S Florida, Dept Neurol, Morsani Coll Med, Tampa, FL USA

[5] State Novosibirsk Reg Clin Hosp, State Budgetary Healthcare Inst Novosibirsk Reg, Novosibirsk, Russia

[6] Med Univ Silesia, Dept Hematol & Bone Marrow Transplantat, Katowice, Poland

[7] Curare Consulting BV, Hamburg, Germany

[8] Cleveland Clin, Cleveland, OH USA

[9] Hanamaki Gen Hosp, Dept Neurol, Hanamaki, Japan

[10] Federico II Univ Naples, NRSO Dept, Naples, Italy

[11] Univ Munster, Dept Neurol, Munster, Germany

[12] Ghent Univ Hosp, Ghent, Belgium

[13] Fdn IRCCS Ist Neurol Carlo Besta, Dept Neuroimmunol & Neuromuscular Dis, Milan, Italy

来源：

NEUROMUSCULAR DISORDERS | 2023年 / 33卷

关键词：

D O I：

10.1016/j.nmd.2023.07.443

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P276

引用

页码：S179 / S179

页数：1

共 50 条

[21] Safety and tolerability of efgartigimod in patients with generalized myasthenia gravis: Phase 3 adapt study results
Mantegazza, Renato
Bril, Vera
Vu, Tuan
Karam, Chafic
Peric, Stojan
Margania, Temur
Murai, Hiroyuki
Bilinska, Malgorzata
Shakarishvili, Roman
Smilowski, Marek
Guglietta, Antonio
Ulrichts, Peter
Vangeneugden, Tony
Utsugisawa, Kimiaki
Verschuuren, Jan
Howard, James
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429
[22] EFFICACY, SAFETY, AND TOLERABILITY OF EFGARTIGIMOD IN ACETYLCHOLINE RECEPTOR AUTOANTIBODY SERONEGATIVE PATIENTS WITH GENERALIZED MYASTHENIA GRAVIS: INTEGRATED INTERIM ANALYSIS OF THE ADAPT AND ADAPT plus STUDIES
Howard, James F., Jr.
Bril, Vera
Tuan Vu
Karam, Chafic
Peric, Stojan
De Bleecker, Jan L.
Murai, Hiroyuki
Pasnoor, Mamatha
Sacca, Francesco
Meisel, Andreas
Guglietta, Antonio
T'joen, Caroline
Utsugisawa, Kimiaki
Verschuuren, Jan
Mantegazza, Renato
MUSCLE & NERVE, 2022, 65 : S13 - S14
[23] EFFICACY, SAFETY, AND TOLERABILITY OF EFGARTIGIMOD IN ANTI-ACETYLCHOLINE RECEPTOR AUTOANTIBODY SERONEGATIVE PATIENTS WITH GENERALIZED MYASTHENIA GRAVIS: INTEGRATED INTERIM ANALYSIS OF ADAPT/ADAPT
Vu, Tuan
Bril, Vera
Karam, Chafic
Peric, Stojan
De Bleecker, Jan
Murai, Hiroyuki
Pasnoor, Mamatha
Sacca, Francesco
Meisel, Andreas
Guglietta, Antonio
T'joen, Caroline
Utsugisawa, Kimiaki
Mantegazza, Renato
Howard, James
MUSCLE & NERVE, 2022, 66 : S54 - S55
[24] Efficacy, Safety, and Tolerability of Efgartigimod in Patients With Generalized Myasthenia Gravis: Analysis of the Phase 3 ADAPT Study
Howard, James
Bril, Vera
Vu, Tuan
Karam, Chafic
Peric, Stojan
Murai, Hiroyuki
Guglietta, Antonio
Ulrichts, Peter
Vangeneugden, Tony
Utsugisawa, Kimiaki
Verschuuren, Jan
Mantegazza, Renato
NEUROLOGY, 2021, 96 (15)
[25] Efficacy and Safety of Subcutaneous Efgartigimod PH20 in Chronic Inflammatory Demyelinating Polyneuropathy: Results of ADHERE/ADHERE
McPhail, Jared
van Doorn, Pieter A.
McPhail, Jared
Allen, Jeffrey A.
Basta, Ivana
Dysgaard, Tina
Eggers, Christian
Guptill, Jeffrey T.
Gwathmey, Kelly
Hewamadduma, Channa
Hofman, Erik
Hussain, Yessar M.
Kuwabara, Satoshi
Le Masson, Gwendal
Leypoldt, Frank
Lin, Jie
Lipowska, Marta
Mole, Trevor
Lauria, Giuseppe
Querol, Luis
Simu, Mihaela-Adriana
Chang, Ting
Ulrichts, Peter
Van Hoorick, Benjamin
Yamasaki, Ryo
Lewis, Richard A.
ANNALS OF NEUROLOGY, 2024, 96 : S75 - S76
[26] EFFICACY AND SAFETY OF SUBCUTANEOUS (SC) EFGARTIGIMOD PH20 IN CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY: ADHERE/ADHERE plus TRIALS
Allen, Jeffrey
Van Doorn, Pieter A.
Basta, Ivana
Dysgaard, Tina
Eggers, Christian
Guptill, Jeffrey
Gwathmey, Kelly
Hewamadduma, Channa
Hofman, Erik
Hussain, Yessar
Kuwabara, Satoshi
Le Masson, Gwendal
Leypoldt, Frank
Lin, Jie
Lipowska, Marta
Lowe, Murray
Pinter, Giuseppe Lauria
Querol, Luis
Simu, Mihaela-Adriana
Chang, Ting
Tse, Anissa
Ulrichts, Peter
Van Hoorick, Benjamin
Yamasaki, Ryo
Lewis, Richard A.
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2024, 29 : S181 - S181
[27] Long-term safety and efficacy of eculizumab in generalized myasthenia gravis
Muppidi, Srikanth
Utsugisawa, Kimiaki
Benatar, Michael
Murai, Hiroyuki
Barohn, Richard J.
Illa, Isabel
Jacob, Saiju
Vissing, John
Burns, Ted M.
Kissel, John T.
Nowak, Richard J.
Andersen, Henning
Casasnovas, Carlos
de Bleecker, Jan L.
Vu, Tuan H.
Mantegazza, Renato
O'Brien, Fanny L.
Wang, Jing Jing
Fujita, Kenji P.
Howard, James F., Jr.
Kaya, Angela
Khursigara, Gus
Armstrong, Roisin
Diab, Diaa
Capocelli, Kelley
Lane, Cindy
Sanders, Vicky
Gandolfo, Ruth
MUSCLE & NERVE, 2019, 60 (01) : 14 - 24
[28] Efficacy and safety of Efgartigimod in patients with generalized myasthenia gravis: interim results of a prospective, single-arm, observational study in China
Liang, H.
Wang, P.
Zhang, B.
Zhao, C.
Huang, S.
NEUROMUSCULAR DISORDERS, 2023, 33 : S177 - S177
[29] SAFETY AND EFFICACY OF SUBCUTANEOUS IMMUNOGLOBULIN IN PATIENTS WITH GENERALIZED MYASTHENIA GRAVIS
Katzberg, Hans
Idiaquez, Juan
Mendoza, Meg
Barnett, Carolina
Huszti, Ella
Lovblom, Erik
Wang, Stella
Bril, Vera
MUSCLE & NERVE, 2024, 70 (03) : 683 - 683
[30] Efficacy and Safety of Efgartigimod PH20 in Chronic Inflammatory Demyelinating Polyneuropathy: Results of ADHERE/ADHERE
Van Doorn, Pieter
Allen, Jeffrey
Basta, Ivana
Dysgaard, Tina
Eggers, Christian
Guptill, Jeff
Gwathmey, Kelly
Hewamadduma, Channa
Hofman, Erik
Hussain, Yessar
Kuwabara, Satoshi
Le Masson, Gwendal
Leypoldt, Frank
Lin, Jie
Lipowska, Marta
Lowe, Murray
Lauria, Giuseppe
Querol, Luis
Simu, Mihaela
Suresh, Niraja
Chang, Ting
Tse, Anissa
Ulrichts, Peter
Van Hoorick, Benjamin
Yamasaki, Ryo
Lewis, Richard
NEUROLOGY, 2024, 103 (07) : S17 - S19

← 1 2 3 4 5 →